default author photo

Shigehira Saji

Fukushima Medical University

Hikari-gaoka 1

Fukushima, 960-1295

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

297

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Postoperative Adjuvant Anastrozole for 10 Rather than 5 Years in Patients with Oestrogen Receptor-Positive Breast Cancer: AERAS, a Randomised Multicentre Open-Label Phase III Trial

Number of pages: 44 Posted: 06 Sep 2021
Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Fukushima Medical University, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, National Hospital Organization Nagoya Medical Center, University of Tsukuba Hospital/Ibaraki Prefectural Central Hospital, Hirosaki Municipal Hospital, Gunma Prefectural Cancer Center, Saitama Cancer Center, CHO Kurume General Hospital, Sapporo Kotoni Breast Clinic, Japanese Foundation for Cancer Research - Department of Breast Surgical Oncology, Kansai Rosai Hospital, Osaka International Cancer Institute, University of Occupational and Environmental Health, Juntendo University and National Cancer Center Hospital East
Downloads 150 (494,203)

Abstract:

Loading...

hormone receptor positive breast cancer, extended adjuvant endocrine therapy, aromatase inhibitor, late recurrence

2.

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase 2 Study

Number of pages: 35 Posted: 06 Apr 2019
National Cancer Center Hospital - Department of Breast and Medical Oncology, Keio University - Department of Clinical Pharmacokinetics and Pharmacodynamics, Toranomon Hospital - Department of Medical Oncology, Fukushima Medical University, Yokohama City University, National Cancer Center Hospital - Department of Breast and Medical Oncology, National Hospital Organization Hokkaido Cancer Center - Department of Breast Surgery, Showa University - Advanced Cancer Translational Research Institute, Kumamoto Shinto General Hospital, Tokyo-West Tokushukai Hospital, Seirei Sakura Citizen Hospital, University of Texas at Houston - MD Anderson Cancer Center, RIKEN Center for Integrative Medical Sciences, RIKEN Center for Integrative Medical Sciences, National Cancer Center Hospital - Department of Breast and Medical Oncology and Keio University - Department of Clinical Pharmacokinetics and Pharmacodynamics
Downloads 147 (502,974)

Abstract:

Loading...

breast cancer, CYP2D6, endoxifen, genotype-guided dosing, tamoxifen